Bioject Medical Technologies In (BJCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2007 | 09-2007 | 06-2007 | 03-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,723 | 611 | 421 | 800 | 1,978 |
| Marketable Securities | 667 | 1,450 | 1,700 | 1,675 | 1,675 |
| Receivables | 847 | 859 | 673 | 1,349 | 1,324 |
| Inventories | 777 | 636 | 962 | 1,369 | 1,058 |
| Other current assets | 324 | 179 | 211 | 224 | 321 |
| TOTAL | $4,338 | $3,735 | $3,968 | $5,417 | $6,355 |
| Non-Current Assets | |||||
| PPE Net | 2,297 | 2,430 | 2,643 | 2,789 | 2,984 |
| Intangibles | 94 | 94 | 94 | 94 | 94 |
| Other Non-Current Assets | 1,240 | 1,277 | 1,283 | 1,232 | 1,191 |
| TOTAL | $3,632 | $3,802 | $4,020 | $4,116 | $4,269 |
| Total Assets | $7,969 | $7,537 | $7,988 | $9,532 | $10,624 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 167 | 250 | 333 | 333 | 333 |
| Accounts payable and accrued liabilities | 1,052 | 719 | 548 | 858 | 584 |
| Accrued Expenses | 308 | 700 | 858 | 1,266 | 1,170 |
| Other current liabilities | 528 | 1,196 | 1,609 | 1,056 | 782 |
| TOTAL | $3,918 | $4,793 | $4,766 | $5,472 | $4,965 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 83 | 167 |
| Deferred Revenues | 316 | 304 | 319 | 967 | 1,167 |
| Other Non-Current Liabilities | 1,540 | 324 | 335 | 347 | 358 |
| TOTAL | $1,642 | $329 | $356 | $467 | $577 |
| Total Liabilities | $5,560 | $5,122 | $5,122 | $5,939 | $5,542 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 15,595 | 15,167 | 15,153 | 15,006 | 14,805 |
| Common Shares | 113,019 | 112,701 | 112,529 | 112,278 | 111,653 |
| Retained earnings | -117,804 | -117,380 | -116,655 | -115,580 | -113,372 |
| Other shareholders' equity | 7,195 | 7,093 | 6,992 | 6,895 | 6,801 |
| TOTAL | $2,409 | $2,414 | $2,866 | $3,594 | $5,082 |
| Total Liabilities And Equity | $7,969 | $7,537 | $7,988 | $9,532 | $10,624 |